Artiva Biotherapeutics (ARTV) Prepaid Assets (2023 - 2026)

Artiva Biotherapeutics (ARTV) has 4 years of Prepaid Assets data on file, last reported at $2.0 million in Q1 2026.

• On a quarterly basis, Prepaid Assets fell 48.57% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $2.0 million, a 48.57% decrease from a year earlier, with the FY2025 full-year figure at $4.6 million, up 50.18% from the prior year.
• Prepaid Assets for Q1 2026 stood at $2.0 million, down from $4.6 million in the prior quarter.
• Over the last five years, Prepaid Assets for ARTV reached as high as $6.7 million in Q2 2025 and fell as low as $1.1 million in Q4 2023.
• Historically, Prepaid Assets has averaged $3.6 million across 4 years, with a median of $3.2 million in 2024.
• Across the five-year window, Prepaid Assets surged 285.16% in 2025 and sank 48.57% in 2026, its largest moves.
• Year by year, Prepaid Assets stood at $1.1 million in 2023, then surged by 179.95% to $3.1 million in 2024, then soared by 50.18% to $4.6 million in 2025, then tumbled by 57.35% to $2.0 million in 2026.
• Per Business Quant data, the three most recent Prepaid Assets figures were $2.0 million in Q1 2026, $4.6 million in Q4 2025, and $6.5 million in Q3 2025.